Industry News Archives - Page 3 of 3 - Fabry International Network

A new tool to capture symptoms for Fabry Disease?
Gallery
A new tool to capture symptoms for Fabry Disease?

A new tool to capture symptoms for Fabry Disease?

Charlotte2021-09-30T12:02:34+02:00

In December 2020 and March 2021, people with Fabry Disease, representing five European countries shared their perspectives on standard questionnaires often used to capture the experiences of people with Fabry Disease and the ideal profile of new tools, designed to more accurately record the Fabry Disease symptoms and impacts. [...]

A new tool to capture symptoms for Fabry Disease?Charlotte2021-09-30T12:02:34+02:00

Amicus Therapeutics Announces European Commission Approval of Galafold® (migalastat) for Adolescents with Fabry Disease

Charlotte2021-09-16T16:08:20+02:00

Amicus Therapeutics Announces European Commission Approval of Galafold® (migalastat) for Adolescents with Fabry Disease

Amicus Therapeutics Announces European Commission Approval of Galafold® (migalastat) for Adolescents with Fabry DiseaseCharlotte2021-09-16T16:08:20+02:00

The study, “Frequency of Fabry disease in a juvenile idiopathic arthritis cohort,” was published in the journal Pediatric Rheumatology

Charlotte2021-09-16T16:04:41+02:00

The study, “Frequency of Fabry disease in a juvenile idiopathic arthritis cohort,” was published in the journal Pediatric Rheumatology.

The study, “Frequency of Fabry disease in a juvenile idiopathic arthritis cohort,” was published in the journal Pediatric RheumatologyCharlotte2021-09-16T16:04:41+02:00

AVROBIO AVR-RD-01 Gene Therapy Trial Now Open to Female Patients

Charlotte2021-09-16T15:38:48+02:00

AVROBIO Provides Regulatory Update on Investigational AVR-RD-01 for Fabry Disease

AVROBIO AVR-RD-01 Gene Therapy Trial Now Open to Female PatientsCharlotte2021-09-16T15:38:48+02:00

AVROBIO Provides Regulatory Update on Investigational AVR-RD-01 for Fabry Disease

Charlotte2021-06-18T15:52:30+02:00

AVROBIO Provides Regulatory Update on Investigational AVR-RD-01 for Fabry Disease

AVROBIO Provides Regulatory Update on Investigational AVR-RD-01 for Fabry DiseaseCharlotte2021-06-18T15:52:30+02:00